Question addressed by the study Methotrexate (MTX) is a key anchor drug for rheumatoid
arthritis (RA) management. Fibrotic interstitial lung disease (ILD) is a common complication of …

Antisynthetase syndrome (ASSD) is a rare clinical condition that is characterized by the
occurrence of a classic clinical triad, encompassing myositis, arthritis, and interstitial lung …

Background Interstitial lung disease (ILD) is the most severe extra‐articular manifestation of
rheumatoid arthritis (RA). Although it is responsible of 10–20% of all RA mortality, no …

The clinical spectrum and prognosis of systemic sclerosis (SSc) seem to vary among patients'
populations recruited during different time periods. In order to verify this possible evolution …

Interstitial lung disease (ILD) is a cause of morbidity and mortality in patients with rheumatic
diseases, such as connective-tissue diseases, rheumatoid arthritis and systemic vasculitis. …

Interstitial lung disease (ILD) is considered the most frequent and serious pulmonary
complication in primary Sjögren’s syndrome (pSS), with the majority of the studies indicating a …

Rheumatoid arthritis (RA) is a chronic and systemic inflammatory disease affecting 0.5–1%
of the population worldwide. Interstitial lung disease (ILD) is a serious pulmonary …

Background Interstitial lung diseases (ILDs) are a heterogeneous group of disorders
characterized by inflammation and/or fibrosis of the lungs, varying from idiopathic interstitial …

Primary Sjögren syndrome (pSS)-related interstitial lung disease (ILD) involved about 10–20%
of patients. In 20% of cases, ILD can be diagnosed before pSS; anyway, few studies have …

Antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) is a group of
systemic vasculitides that predominantly affect small vessels, including granulomatosis with …